Icahn Boosts Stake In Amylin (AMLN), Look For a Future Sale
It's been a while since we posted here. Due to the credit crisis we've been super busy at the main StreetInsider.com site. In addition, there haven't been too many 13Ds worth mentioning. We are going to start posting frequently again.
Today, there was an interesting filing from one of our favorites Carl Icahn on Amylin Pharmaceuticals (Nasdaq: AMLN). He's been a holder there for a long time, but now he is seeking to get a slate of 5 on the Board of Directors. We have a great article over at StreetInsider.com for premium members, discussing how "Like ImClone, Ichan Will Get Amylin Sold."